Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
19.12
-0.38 (-1.95%)
At close: Oct 10, 2025, 4:00 PM EDT
19.51
+0.39 (2.04%)
After-hours: Oct 10, 2025, 6:22 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $167.39 million as of October 10, 2025. Its market cap has increased by 20.51% in one year.
Market Cap
167.39M
Enterprise Value
209.44M
1-Year Change
20.51%
Ranking
Category
Stock Price
$19.12
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $167.39M, a decrease of -91.12%. That is a compound annual growth rate of -20.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 167.40M | 17.97% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
| Jun 26, 2015 | 1.88B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |